XML 45 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Shareholders' Equity and Debt (Shareholders' Equity) (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 30, 2019
Nov. 30, 2017
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2020
Sep. 30, 2019
Jan. 31, 2016
May 13, 2010
Shareholders' Equity (Textual) [Abstract]                        
Repurchase outstanding common shares                     $ 10,000,000 $ 10,000,000
Repurchase of shares (in shares)                 10,080      
Repurchase of shares, value     $ (332,504) $ (769,648) $ (441,624) $ (1,361,689) $ (531,746) $ (703,790)        
Shelf Registration, sale of corporate securities (up to)   $ 100,000,000                    
Contribution of cash $ 300,000                      
Conversion of intercompany loans payable 700,000                      
WinHealth                        
Shareholders' Equity (Textual) [Abstract]                        
Investment through purchase of shares of CET Stock 1,000,000                      
Gloria Pharmaceuticals                        
Shareholders' Equity (Textual) [Abstract]                        
Cash payments for return of shares $ 800,000                      
Restricted Stock                        
Shareholders' Equity (Textual) [Abstract]                        
Restricted stock granted in period, shares                 230,491 225,869    
Director | Restricted Stock                        
Shareholders' Equity (Textual) [Abstract]                        
Restricted stock awards, vesting period                 1 year      
Common stock                        
Shareholders' Equity (Textual) [Abstract]                        
Repurchase of shares (in shares)     101,354 141,463 164,866 246,242 84,447 121,466 407,683 452,155    
Repurchase of shares, value     $ (332,504) $ (769,648) $ (441,624) $ (1,361,689) $ (531,746) $ (703,790) $ (1,500,000) $ (2,600,000)